J Bacteriol Virol.  2015 Dec;45(4):394-396. 10.4167/jbv.2015.45.4.394.

High-fat-diet-modulated Gut Microbiota Promotes Intestinal Carcinogenesis

Affiliations
  • 1Department of Microbiology and Immunology, School of Medicine and Brain Korea 21 PLUS Program, and Institute of Medical Science, Jeju National University, Jeju, Korea. yskoh7@jejunu.ac.kr

Abstract

Gut microbiota play a critical role in the development of intestinal cancer. Dietary changes cause dysbiosis of gut microbiota that mediates production of dietary factors triggering intestinal cancer. Genetic and dietary factors work in different combinatorial ways in initiation and progression of intestinal cancer, one of which is changes in gut microbiota. Recently, it has been found that high-fat-diet promote intestinal tumorigenesis in a genetically susceptible K-ras(G12Dint) mice without induction of obesity. High-fat-diet along with oncogene activation dampened paneth-cell mediated immunity and thus shift bacterial communities in such a way that promotes intestinal cancer.

Keyword

Gut microbiota; Intestinal cancer; High-fat-diet; K-ras(G12Dint); Paneth cell

MeSH Terms

Animals
Carcinogenesis*
Dysbiosis
Intestinal Neoplasms
Mice
Microbiota*
Obesity
Oncogenes

Cited by  1 articles

Suppression of Antimicrobial Defense and Stabilization of STAT3 by IRAK-M Expression in Tumor Cells Promotes Colorectal Carcinogenesis
Irshad Ali, Young-Sang Koh
J Bacteriol Virol. 2016;46(3):181-183.    doi: 10.4167/jbv.2016.46.3.181.


Reference

1). Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014; 514:508–12.
Article
2). Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med. 2010; 16:665–70.
3). Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome driven inflammation with transmissible cancer. Proc Natl Acad Sci U S A. 2013; 110:9862–7.
4). Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012; 338:120–3.
Article
5). Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40:128–39.
Article
6). Wang D, Peregrina K, Dhima E, Lin EY, Mariadason JM, Augenlicht LH. Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer. Proc Natl Acad Sci U S A. 2011; 108:10272–7.
Article
7). Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, Glickman JN, et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet. 2008; 40:600–8.
Article
8). Manzoor Z, Koo JE, Koh YS. Mitogen-activated protein kinases signaling in inflammation-related carcinogenesis. J Bacteriol Virol. 2014; 44:297–304.
Full Text Links
  • JBV
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr